[ad_1] Chemotherapy-free approaches could offer comparable efficacy with less toxicity ORLANDO, Fla., Dec. 7, 2025 /PRNewswire/ — Targeted therapies and immunotherapies are increasingly offering viable alternatives to the chemotherapies that have stood for decades as […]

[ad_1] Emerging tests and treatment strategies guide more tailored approaches and ease the burden on patients ORLANDO, Fla., Dec. 6, 2025 /PRNewswire/ — Four clinical trials to be presented at the 67th American Society of […]

[ad_1] With an emphasis on real-world data, studies guide application of both longstanding and emerging therapies ORLANDO, Fla., Dec. 6, 2025 /PRNewswire/ — Five studies presented at the 67th American Society of Hematology (ASH) Annual […]

[ad_1] New research re-examines existing practices, identifies gaps and unmet needs ORLANDO, Fla., Dec. 6, 2025 /PRNewswire/ — Four studies presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition spotlight how […]

[ad_1] Advances across continuum of care show promise and hope for patients SAN DIEGO, Dec. 8, 2024 /PRNewswire/ — Studies being presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition highlight progress […]